Launching a new brand in the Indian health-tech market is often a slow process, but Vevo HealthTech managed to defy the odds. Between 12 August and 20 October 2026, the brand achieved a 4.61x Return on Ad Spend (ROAS) on Meta. This D2C Meta ads case study India highlights how Vevo generated Rs 4.16 L in sales from 419 orders, starting from a baseline of zero. By focusing on data-driven creative testing and granular performance monitoring, they successfully navigated the challenges required to launch D2C brand from zero in a highly competitive digital landscape.

The Challenge: How to Launch D2C Brand from Zero in a Saturated Market

Vevo HealthTech entered a market where consumer trust is hard to earn and competition for attention is fierce. When you launch D2C brand from zero, you face the double hurdle of building brand awareness while simultaneously trying to maintain a positive ROAS. For Vevo, the goal was not just to spend money on ads, but to find a sustainable way to acquire customers at an efficient cost.

The brand lacked historical data, which meant the Meta algorithm needed time to learn who the ideal customers were. In the early weeks, the cost per acquisition was high, and the conversion rate was unpredictable. The team needed a way to identify winning ad creatives quickly without draining the entire marketing budget on underperforming campaigns. They also had to prepare for the upcoming Diwali season, a period when ad costs typically spike across India.

The Strategy: A Data-Driven Approach to Meta Ads

To move from zero to a 4.61x ROAS, Vevo HealthTech adopted a three pillar strategy focused on creative diversification, audience testing, and real-time monitoring. Instead of relying on a single “hero” ad, they tested multiple formats including user-generated content, expert testimonials, and clean product benefit shots.

The campaign structure was divided into three distinct phases:

• Phase 1: Discovery (Weeks 1 to 3). Broad targeting was used to let the Meta algorithm identify interest clusters. The team focused on high-level metrics like Click-Through Rate (CTR) to see which messages resonated.
• Phase 2: Optimization (Weeks 4 to 7). Budget was shifted toward the highest-performing ad sets. This is where this ROAS case study begins to show significant traction as the ad cost per order stabilized.
• Phase 3: Scaling (Weeks 8 to 10). With a clear understanding of the winning creatives, the team increased daily spend while maintaining the 4.61x ROAS target.

Using Ad Intelligence for Faster Scaling

One of the biggest hurdles for any new brand is the “lag” in reporting. Waiting for weekly reports often means wasting budget on ads that stopped performing days ago. To counter this, Vevo utilized Eagle by RaySuite AI to gain live performance insights. This tool allowed the team to monitor ad intelligence and receive automatic reports that highlighted which specific creatives were driving the Rs 4.16 L in sales.

By having a clear view of the data, the team could make decisions in hours rather than days. For example, if a specific video ad showed a drop in ROAS on a Tuesday morning, the team could pause it and redirect funds to a better-performing static image before the daily budget was exhausted. This level of agility is critical when you want to launch D2C brand from zero and ensure every rupee spent contributes to the bottom line.

D2C Meta Ads Case Study India: Breaking Down the Results

The 10 week period from August to October 2026 provided a wealth of data that proves the effectiveness of a disciplined Meta strategy. The following table summarizes the key performance indicators (KPIs) achieved by Vevo HealthTech during this window:

Achieving an average ad cost per order of approximately Rs 208 was a significant milestone for Vevo. In the health-tech sector, where customer acquisition costs often exceed Rs 500 for new brands, Vevo’s lean approach allowed them to scale profitably. This D2C Meta ads case study India serves as a blueprint for other startups looking to achieve high efficiency in a short time frame.

Creative Insights That Drove Conversions

The team found that simple, benefit-driven messaging performed 30 percent better than overly polished, high-production commercials. Consumers in the Indian market responded well to “Problem-Solution” frameworks. By highlighting a specific health pain point and showing how Vevo HealthTech solved it within the first three seconds of a video, the brand significantly lowered its cost per click.

Lessons from This ROAS Case Study

For D2C founders and performance marketers, the Vevo HealthTech journey offers several actionable takeaways. Profitability on Meta is rarely about the “perfect” campaign setting: it is about the combination of creative resonance and rigorous data monitoring.

First, patience during the learning phase is vital. Vevo did not panic when the first week’s ROAS was below 2.0x. They used that time to gather data on what didn’t work. Second, the use of automated reporting and ad intelligence tools changed the game. Using Eagle by RaySuite AI provided the visibility needed to trust the scaling process. Without live performance insights, the team would have been flying blind during the critical weeks leading up to the Diwali sales period.

Finally, regional targeting in India requires nuance. Vevo tracked which cities were driving the highest ROAS and adjusted their bidding strategy to favor high-intent urban areas. This ensured that the limited budget was always working in the most fertile ground.

Conclusion: Preparing for the Diwali Surge

Vevo HealthTech’s success in achieving a 4.61x ROAS over 10 weeks demonstrates that even a brand starting from scratch can find a foothold in the Indian market. By generating 419 orders and Rs 4.16 L in revenue within two months, they have built a solid foundation for the festive season. As the Diwali shopping peak approaches, Vevo is well-positioned to scale even further using the same data-led principles.

As the founder of Vevo HealthTech noted, “The clarity we gained by monitoring our live performance allowed us to stop guessing and start growing. Reaching 4.61x ROAS while launching from zero gave us the confidence to invest more aggressively in our mission.”

If you are looking to replicate these results for your own brand, the next step is to move beyond basic dashboards. Start by auditing your creative performance and implementing a system that gives you real-time visibility into your ad spend efficiency.

Frequently Asked Questions

How long does it take to see a high ROAS for a new D2C brand?

While every brand is different, Vevo HealthTech saw significant optimization by week four. Generally, the first three weeks are for data collection, while the subsequent weeks focus on scaling what works to reach targets like a 4x ROAS or higher.

What is a good ad cost per order for Indian D2C brands?

In this ROAS case study, Vevo achieved an ad cost per order of approximately Rs 208. Depending on your product’s average order value and margins, anything between Rs 200 and Rs 400 is often considered a healthy range for a scaling D2C brand in the Indian market.

How important is creative testing in a D2C Meta ads case study?

Creative testing is the most important lever for success. Vevo tested multiple formats and found that the creative was the primary driver of their 4.61x ROAS, more so than technical targeting hacks or audience segments.